James Sandy

James Sandy

Chief Development Officer
Over 35 years experience in pharmaceutical R&D covering a wide range of therapeutic areas and development phases from Ph I to IV. Previously held positions at large in large pharma(Astra and Pfizer) and Biotech, taken several assets to global filings and approval. Previously held a variety of senior positions including VP European and Asian development operations and project management at Pfizer, and chief development officer(CDO) roles at four Biotech’s. Within the sphere of Biotech, bespoke development organizations have been built to support the development of proprietary Oncology assets.